Developing New Therapies
for Diseases with Significant
Unmet Medical Needs

Vitae Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovering and developing novel, small molecule drugs for diseases with significant unmet medical needs.The company leverages its structure-based drug design platform, Contour®, creating a robust and growing portfolio of product candidates.

Vitae Pharmaceuticals is developing and plans to commercialize multiple product candidates including its innovative RORγt program to treat various autoimmune diseases.

Vitae Pharmaceuticals develops drugs for "difficult-to-drug" targets. Click to learn more.


Vitae’s Mission

Vitae Pharmaceuticals’ mission is to rapidly discover, develop and commercialize first-in-class or best-in-class product candidates for validated but “difficult-to-drug” targets in multiple disease areas.

Learn More

What is Contour®?

Contour® is Vitae Pharmaceuticals’ computationally-based proprietary SBDD technology platform that the company’s team of scientists leverages to discover and develop novel therapies for “difficult-to-drug” targets.

Discover Contour®


RORγt Program

Vitae Pharmaceuticals’ RORγt program produced VTP-43742, which holds the promise of being a first-in-class, oral, once-a-day drug for autoimmune diseases including psoriasis, multiple sclerosis, and rheumatoid arthritis.

Get More Info


Efficient Drug Discovery

Vitae Pharmaceuticals values innovation, quality and speed.
The clinical stage biopharmaceutical company produces orally-active novel leads in less than 18 months from the start of a program.

View Pipeline

Company Culture

Vitae Pharmaceuticals has an innovative, team-oriented culture which has been honored with The Scientist’s Best Places to Work and The Best Places to Work in PA awards each year since 2010.

See Career Opportunities